Macrae Sandy (CIK 0001675687)

Latest company ownership

Shares held
2,049,534
Last filed at
Nov 26, 2025
Confidence Score
45.4
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 24, 2025 Nov 26, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 52.5 -7,488 -0.36% $3.1K
Oct 22, 2025 Oct 24, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 42.5 -126,950 -5.81% $83.8K
Aug 24, 2025 Aug 26, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 52.5 -7,488 -0.34% $4.4K
Jul 22, 2025 Jul 24, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 42.5 -126,950 -5.48% $60.9K
May 24, 2025 May 28, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 52.5 -7,488 -0.32% $3.5K
Apr 22, 2025 Apr 24, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 42.5 -126,950 -5.18% $98.6K
Feb 24, 2025 Feb 26, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 91.3 +356,849 17.03% $17.7K
Jan 22, 2025 Jan 24, 2025 SANGAMO THERAPEUTICS, INC CEO Sell 40.0 -412,584 -16.45% $474.5K
Nov 24, 2024 Nov 26, 2024 SANGAMO THERAPEUTICS, INC CEO Sell 48.8 -18,115 -0.72% $34.7K
Aug 24, 2024 Aug 27, 2024 SANGAMO THERAPEUTICS, INC CEO Sell 48.8 -12,753 -0.50% $11K
May 24, 2024 May 29, 2024 SANGAMO THERAPEUTICS, INC CEO Sell 52.5 -12,753 -0.50% $7.7K
Feb 24, 2024 Feb 27, 2024 SANGAMO THERAPEUTICS, INC CEO Sell 46.3 -40,272 -1.55% $45.5K
Nov 25, 2023 Nov 28, 2023 SANGAMO THERAPEUTICS, INC CEO Sell 47.5 -10,411 -1.73% $4K
Aug 25, 2023 Aug 29, 2023 SANGAMO THERAPEUTICS, INC CEO Sell 47.5 -10,411 -1.70% $8K
May 25, 2023 May 30, 2023 SANGAMO THERAPEUTICS, INC CEO Sell 46.3 -10,411 -1.67% $13.8K
Feb 24, 2023 Mar 6, 2023 SANGAMO THERAPEUTICS, INC CEO Sell 95.0 +102,533 19.67% $145.7K
Feb 25, 2022 Mar 1, 2022 SANGAMO THERAPEUTICS, INC CEO Sell 97.5 +174,110 50.17% $294.4K
Feb 25, 2021 Mar 1, 2021 SANGAMO THERAPEUTICS, INC CEO Sell 97.5 +103,064 42.24% $395.1K
Jan 24, 2021 Jan 26, 2021 SANGAMO THERAPEUTICS, INC CEO Sell 42.5 -3,977 -1.60% $59.5K
Feb 25, 2020 Feb 26, 2020 SANGAMO THERAPEUTICS, INC CEO Sell 91.3 +161,486 186.70% $49.4K
Jan 24, 2020 Jan 28, 2020 SANGAMO THERAPEUTICS, INC CEO Sell 46.3 -4,283 -4.72% $32.1K
Jan 24, 2018 Jan 28, 2019 SANGAMO THERAPEUTICS, INC CEO Sell 46.3 -3,974 -12.62% $44.1K